Sidus Space Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Sidus Space Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.38M | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | $4.67M | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | $5.96M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $7.29M | Oct 11, 2024 |
| FY2022 | Dec 31, 2021 | $1.41M | Mar 15, 2023 |
| FY2021 | Dec 31, 2020 | $1.81M | Apr 5, 2022 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.78M | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | $3.87M | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | $5.01M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $6.25M | Oct 11, 2024 |
| FY2022 | Dec 31, 2021 | $789.4K | Mar 15, 2023 |
| FY2021 | Dec 31, 2020 | $1.63M | Apr 5, 2022 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($5.69M) | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | ($1.47M) | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | $1.64M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $1.44M | Oct 11, 2024 |
| FY2022 | Dec 31, 2021 | ($366.6K) | Mar 15, 2023 |
| FY2021 | Dec 31, 2020 | $20.8K | Apr 5, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($29.47M) | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | ($17.52M) | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | ($14.33M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($12.84M) | Oct 11, 2024 |
| FY2022 | Dec 31, 2021 | ($3.75M) | Mar 15, 2023 |
| FY2021 | Dec 31, 2020 | ($1.54M) | Apr 5, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($28.01M) | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | ($15.72M) | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | ($12.53M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($12.04M) | Oct 11, 2024 |
| FY2022 | Dec 31, 2021 | ($3.51M) | Mar 15, 2023 |
| FY2021 | Dec 31, 2020 | ($1.53M) | Apr 5, 2022 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.32M | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | $14.25M | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | $14.17M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $13.48M | Oct 11, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($18.15M) | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | ($15.83M) | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | ($11.75M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($12.09M) | Oct 11, 2024 |
| FY2022 | Dec 31, 2021 | ($2.48M) | Mar 15, 2023 |
| FY2021 | Dec 31, 2020 | ($1.59M) | Apr 5, 2022 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.17M | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | $7.47M | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | $7.21M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $2.10M | Oct 11, 2024 |
| FY2022 | Dec 31, 2021 | $217.8K | Mar 15, 2023 |
| FY2021 | Dec 31, 2020 | $4.5K | Apr 5, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $66.09M | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | $37.75M | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | $19.35M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $10.30M | Oct 11, 2024 |
| FY2022 | Dec 31, 2021 | $17.30M | Mar 15, 2023 |
| FY2021 | Dec 31, 2020 | $1.84M | Apr 5, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.46M | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | $14.21M | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | $12.22M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $6.42M | Oct 11, 2024 |
| FY2022 | Dec 31, 2021 | $6.64M | Mar 15, 2023 |
| FY2021 | Dec 31, 2020 | $8.43M | Apr 5, 2022 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $50.64M | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | $23.54M | Apr 1, 2026 |
| FY2025 | Dec 31, 2023 | $7.13M | Apr 1, 2026 |
| FY2024 | Dec 31, 2022 | $3.88M | Mar 31, 2025 |
| FY2023 | Dec 31, 2021 | $10.66M | Oct 11, 2024 |
| FY2022 | Dec 31, 2020 | ($6.59M) | Mar 15, 2023 |
| FY2021 | Dec 31, 2019 | ($5.04M) | Apr 5, 2022 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($89.83M) | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | ($60.35M) | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | ($42.79M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($28.26M) | Oct 11, 2024 |
| FY2022 | Dec 31, 2021 | ($15.42M) | Mar 15, 2023 |
| FY2021 | Dec 31, 2020 | ($11.67M) | Apr 5, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $13.71M | Apr 5, 2022 |
| FY2021 | Dec 31, 2020 | $20.2K | Apr 5, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | (3) | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | (23) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | (74) | Oct 11, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 15, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | (3) | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | (23) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | (74) | Oct 11, 2024 |